Publikation:

Expression of high- and low-affinity receptors for C3a on the human mast cell line, HMC-1

Lade...
Vorschaubild

Dateien

Zu diesem Dokument gibt es keine Dateien.

Datum

1996

Autor:innen

Loetscher, Marcel
Jones, Simon A.
Dahinden, Clemens A.
Arock, Michel
Moser, Bernhard

Herausgeber:innen

Kontakt

ISSN der Zeitschrift

Electronic ISSN

ISBN

Bibliografische Daten

Verlag

Schriftenreihe

Auflagebezeichnung

URI (zitierfähiger Link)
ArXiv-ID

Internationale Patentnummer

Angaben zur Forschungsförderung

Projekt

Open Access-Veröffentlichung
Core Facility der Universität Konstanz

Gesperrt bis

Titel in einer weiteren Sprache

Publikationstyp
Zeitschriftenartikel
Publikationsstatus
Published

Erschienen in

European Journal of Immunology. 1996, 26(4), pp. 753-758. ISSN 0014-2980. eISSN 1521-4141. Available under: doi: 10.1002/eji.1830260405

Zusammenfassung

The proteolytic cleavage product of complement component 3, (C3a), is like C4a and C5a, is a potent anaphylatoxin and induces the production of inflammatory mediators in phagocytes. Notably, mast cells respond to C3a with the release of vasoactive substances, including histamine. We have examined the function and receptor binding of C3a in a human leukemic mast cell line, HMC-1. Similar to chemoattractant agonists in leukocytes, C3a induced rapid cytosolic free calcium concentration increases in HMC-1 cells. EGTA did not diminish this response, indicating that mobilizable Ca2+ was from intracellular stores. Receptors of C3a in HMC-1 cells couple in part to Bordetella pertussis toxin-sensitive G-proteins and, therefore, appear to belong to the family of serpentine receptors that require G-proteins for signal transduction. HMC-1 cells express two types of C3a receptors, C3aR1 and C3aR2, that were shown to bind 125I-C3a with high-(Kd1 = 2.1-4.8 nM) or low-affinity (Kd2 = 30-150 nM), and both receptors are expressed at high level: 3 x 105-6 x 105 C3aR1/cell and 5 x 105-2.3 x 106 C3aR2/cell. Results from cross-linking experiments with 125I-C3a fully agree with the presence of two different classes of C3a receptors in HMC-1 cells. Two membrane proteins with apparent molecular masses of 54-61 kDa (p57) and 86-107 kDa (p97) could be covalently modified with 125I-C3a, and this cross-linking was inhibited with an excess of unlabeled C3a. Many of the known agonists for leukocytes including 13 chemokines (IL-8, NAP-2, GRO alpha, ENA-78, IP10, PF4, MCP-1, 2 and 3, RANTES, MIP-1 alpha, MIP-1 beta and I309), three neuropeptides (neuropeptide Y, somatostatin and calcitonin), as well as C5a, did not activate HMC-1 cells, indicating that C3a is one of a few protein ligands for which this cell line expresses specific receptors. The apparent selectivity for C3a and the abundant expression of C3a receptors make the HMC-1 cell line an excellent choice for the cloning of the receptor genes.

Zusammenfassung in einer weiteren Sprache

Fachgebiet (DDC)
570 Biowissenschaften, Biologie

Schlagwörter

Konferenz

Rezension
undefined / . - undefined, undefined

Forschungsvorhaben

Organisationseinheiten

Zeitschriftenheft

Verknüpfte Datensätze

Zitieren

ISO 690LEGLER, Daniel F., Marcel LOETSCHER, Simon A. JONES, Clemens A. DAHINDEN, Michel AROCK, Bernhard MOSER, 1996. Expression of high- and low-affinity receptors for C3a on the human mast cell line, HMC-1. In: European Journal of Immunology. 1996, 26(4), pp. 753-758. ISSN 0014-2980. eISSN 1521-4141. Available under: doi: 10.1002/eji.1830260405
BibTex
@article{Legler1996-04Expre-37200,
  year={1996},
  doi={10.1002/eji.1830260405},
  title={Expression of high- and low-affinity receptors for C3a on the human mast cell line, HMC-1},
  number={4},
  volume={26},
  issn={0014-2980},
  journal={European Journal of Immunology},
  pages={753--758},
  author={Legler, Daniel F. and Loetscher, Marcel and Jones, Simon A. and Dahinden, Clemens A. and Arock, Michel and Moser, Bernhard}
}
RDF
<rdf:RDF
    xmlns:dcterms="http://purl.org/dc/terms/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:bibo="http://purl.org/ontology/bibo/"
    xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#"
    xmlns:foaf="http://xmlns.com/foaf/0.1/"
    xmlns:void="http://rdfs.org/ns/void#"
    xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > 
  <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/37200">
    <dc:contributor>Jones, Simon A.</dc:contributor>
    <bibo:uri rdf:resource="https://kops.uni-konstanz.de/handle/123456789/37200"/>
    <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2017-02-08T07:43:11Z</dc:date>
    <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <dc:creator>Loetscher, Marcel</dc:creator>
    <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2017-02-08T07:43:11Z</dcterms:available>
    <dc:contributor>Arock, Michel</dc:contributor>
    <dc:contributor>Moser, Bernhard</dc:contributor>
    <dc:creator>Jones, Simon A.</dc:creator>
    <dc:creator>Legler, Daniel F.</dc:creator>
    <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <dc:creator>Moser, Bernhard</dc:creator>
    <dc:contributor>Legler, Daniel F.</dc:contributor>
    <dcterms:abstract xml:lang="eng">The proteolytic cleavage product of complement component 3, (C3a), is like C4a and C5a, is a potent anaphylatoxin and induces the production of inflammatory mediators in phagocytes. Notably, mast cells respond to C3a with the release of vasoactive substances, including histamine. We have examined the function and receptor binding of C3a in a human leukemic mast cell line, HMC-1. Similar to chemoattractant agonists in leukocytes, C3a induced rapid cytosolic free calcium concentration increases in HMC-1 cells. EGTA did not diminish this response, indicating that mobilizable Ca&lt;sup&gt;2+&lt;/sup&gt; was from intracellular stores. Receptors of C3a in HMC-1 cells couple in part to Bordetella pertussis toxin-sensitive G-proteins and, therefore, appear to belong to the family of serpentine receptors that require G-proteins for signal transduction. HMC-1 cells express two types of C3a receptors, C3aR1 and C3aR2, that were shown to bind &lt;sup&gt;125&lt;/sup&gt;I-C3a with high-(K&lt;sub&gt;d&lt;/sub&gt;1 = 2.1-4.8 nM) or low-affinity (K&lt;sub&gt;d&lt;/sub&gt;2 = 30-150 nM), and both receptors are expressed at high level: 3 x 10&lt;sup&gt;5&lt;/sup&gt;-6 x 10&lt;sup&gt;5&lt;/sup&gt; C3aR1/cell and 5 x 10&lt;sup&gt;5&lt;/sup&gt;-2.3 x 10&lt;sup&gt;6&lt;/sup&gt; C3aR2/cell. Results from cross-linking experiments with &lt;sup&gt;125&lt;/sup&gt;I-C3a fully agree with the presence of two different classes of C3a receptors in HMC-1 cells. Two membrane proteins with apparent molecular masses of 54-61 kDa (p57) and 86-107 kDa (p97) could be covalently modified with &lt;sup&gt;125&lt;/sup&gt;I-C3a, and this cross-linking was inhibited with an excess of unlabeled C3a. Many of the known agonists for leukocytes including 13 chemokines (IL-8, NAP-2, GRO alpha, ENA-78, IP10, PF4, MCP-1, 2 and 3, RANTES, MIP-1 alpha, MIP-1 beta and I309), three neuropeptides (neuropeptide Y, somatostatin and calcitonin), as well as C5a, did not activate HMC-1 cells, indicating that C3a is one of a few protein ligands for which this cell line expresses specific receptors. The apparent selectivity for C3a and the abundant expression of C3a receptors make the HMC-1 cell line an excellent choice for the cloning of the receptor genes.</dcterms:abstract>
    <dcterms:issued>1996-04</dcterms:issued>
    <dc:creator>Arock, Michel</dc:creator>
    <dc:contributor>Loetscher, Marcel</dc:contributor>
    <dc:language>eng</dc:language>
    <dc:creator>Dahinden, Clemens A.</dc:creator>
    <dcterms:title>Expression of high- and low-affinity receptors for C3a on the human mast cell line, HMC-1</dcterms:title>
    <foaf:homepage rdf:resource="http://localhost:8080/"/>
    <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/>
    <dc:contributor>Dahinden, Clemens A.</dc:contributor>
  </rdf:Description>
</rdf:RDF>

Interner Vermerk

xmlui.Submission.submit.DescribeStep.inputForms.label.kops_note_fromSubmitter

Kontakt
URL der Originalveröffentl.

Prüfdatum der URL

Prüfungsdatum der Dissertation

Finanzierungsart

Kommentar zur Publikation

Allianzlizenz
Corresponding Authors der Uni Konstanz vorhanden
Internationale Co-Autor:innen
Universitätsbibliographie
Nein
Begutachtet
Diese Publikation teilen